Table 1

Relationship between the T:N ratio of DRH1 expression and clinicopathological features in 35 patients with HCC

Clinical featuresnT:N ratioaP
Age (yr)0.59
≤65160.59 ± 0.10
>65190.67 ± 0.12
Sex0.66
Male280.65 ± 0.09
Female70.57 ± 0.10
Virus
HBVb80.38 ± 0.050.03c
HCVd230.77 ± 0.11
NBNCe40.34 ± 0.12
Serum AFP (ng/ml)0.006
≤100210.80 ± 0.11
>100140.38 ± 0.09
Tumor size (cm)0.02
≤3120.87 ± 0.14
>3230.51 ± 0.09
Differentiation
Well31.15 ± 0.23
Moderate230.69 ± 0.100.002f
Poor90.19 ± 0.040.002g
Macroscopic type0.18
1110.82 ± 0.15
2180.61 ± 0.11
350.37 ± 0.07
Other10.44
Vascular invasion0.002
Present (+)220.46 ± 0.07
Absent (−)130.94 ± 0.16
  • a Mean ± SE.

  • b HBV; hepatitis B surface antigen positive.

  • c P of HBV relative to HCV.

  • d HCV; hepatitis C virus antibody positive.

  • e NBNC; patients without HBV or HCV infection.

  • f P of moderate relative to well.

  • g P of poor relative to moderate.